RARE
Ultragenyx to Host Conference Call for First Quarter 2023 Financial Results and Corporate Update
Thursday, April 27, 2023 BiopharmaWatch Research 1 min read Key Takeaway: Ultragenyx to Host Conference Call for First Quarter 2023 Financial Results and Corporate Update
Price reaction · baseline $42.33 (2023-04-26 close) · hit after-hours · clean, no other RARE news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+43%
120-day peak, hindsight
Typical move
2.9%
average across 6 past catalysts
Cash runway
~13 mo
Low dilution risk
Lead asset
BPS804
Phase 2 · Hypophosphatasia
Full Press Release Details
Ultragenyx to Host Conference Call for First Quarter 2023 Financial Results and Corporate Update.